Male Breast Cancer Active Not Recruiting Phase 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01372579Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer PatientsTreatment